These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32846108)

  • 1. Efficacy of Bolus Calculation and Advanced Carbohydrate Counting in Type 2 Diabetes: A Randomized Clinical Trial.
    Christensen MB; Serifovski N; Herz AMH; Schmidt S; Hommel E; Raimond L; Perrild H; Gotfredsen A; Gæde P; Nørgaard K
    Diabetes Technol Ther; 2021 Feb; 23(2):95-103. PubMed ID: 32846108
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of advanced carbohydrate counting guided by an automated bolus calculator in Type 1 diabetes mellitus (StenoABC): a 12-month, randomized clinical trial.
    Hommel E; Schmidt S; Vistisen D; Neergaard K; Gribhild M; Almdal T; Nørgaard K
    Diabet Med; 2017 May; 34(5):708-715. PubMed ID: 27761942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial.
    Secher AL; Pedersen-Bjergaard U; Svendsen OL; Gade-Rasmussen B; Almdal T; Raimond L; Vistisen D; Nørgaard K
    Diabetologia; 2021 Dec; 64(12):2713-2724. PubMed ID: 34495375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study protocol for optimising glycaemic control in type 1 diabetes treated with multiple daily insulin injections: intermittently scanned continuous glucose monitoring, carbohydrate counting with automated bolus calculation, or both? A randomised controlled trial.
    Secher AL; Pedersen-Bjergaard U; Svendsen OL; Gade-Rasmussen B; Almdal TP; Dørflinger L; Vistisen D; Nørgaard K
    BMJ Open; 2020 Apr; 10(4):e036474. PubMed ID: 32345699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Automated Bolus Calculation on Glucose Variability and Quality of Life in Patients With Type 1 Diabetes on CSII Treatment.
    van Meijel LA; van den Heuvel-Bens SP; Zimmerman LJ; Bazelmans E; Tack CJ; de Galan BE
    Clin Ther; 2018 Jun; 40(6):862-871. PubMed ID: 29502804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbohydrate counting with an automated bolus calculator helps to improve glycaemic control in children with type 1 diabetes using multiple daily injection therapy: an 18-month observational study.
    Rabbone I; Scaramuzza AE; Ignaccolo MG; Tinti D; Sicignano S; Redaelli F; De Angelis L; Bosetti A; Zuccotti GV; Cerutti F
    Diabetes Res Clin Pract; 2014 Mar; 103(3):388-94. PubMed ID: 24447811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trial.
    Heller S; Koenen C; Bode B
    Clin Ther; 2009 Oct; 31(10):2086-97. PubMed ID: 19922879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Benefit of Insulin Degludec/Liraglutide (IDegLira) Compared With Basal-Bolus Insulin Therapy is Consistent Across Participant Subgroups With Type 2 Diabetes in the DUAL VII Randomized Trial.
    Billings LK; Agner BFR; Altuntas Y; Grøn R; Halladin N; Klonoff DC; Tentolouris N; Jódar E
    J Diabetes Sci Technol; 2021 May; 15(3):636-645. PubMed ID: 32107930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring factors influencing HbA1c and psychosocial outcomes in people with type 1 diabetes after training in advanced carbohydrate counting.
    Schmidt S; Vistisen D; Almdal T; Hommel E; Nørgaard K
    Diabetes Res Clin Pract; 2017 Aug; 130():61-66. PubMed ID: 28570925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycaemic load versus carbohydrate counting for insulin bolus calculation in patients with type 1 diabetes on insulin pump.
    Bozzetto L; Giorgini M; Alderisio A; Costagliola L; Giacco A; Riccardi G; Rivellese AA; Annuzzi G
    Acta Diabetol; 2015 Oct; 52(5):865-71. PubMed ID: 25697600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.
    Hollander P; Cooper J; Bregnhøj J; Pedersen CB
    Clin Ther; 2008 Nov; 30(11):1976-87. PubMed ID: 19108786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial.
    Rodbard HW; Visco VE; Andersen H; Hiort LC; Shu DH
    Lancet Diabetes Endocrinol; 2014 Jan; 2(1):30-7. PubMed ID: 24622667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5.
    Buse JB; Rodbard HW; Trescoli Serrano C; Luo J; Ivanyi T; Bue-Valleskey J; Hartman ML; Carey MA; Chang AM;
    Diabetes Care; 2016 Jan; 39(1):92-100. PubMed ID: 26577417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.
    Roach ; Koledova E; Metcalfe S; Hultman C; Milicevic Z;
    Clin Ther; 2001 Oct; 23(10):1732-44. PubMed ID: 11726007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
    Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Schwarz E; Ólafsdóttir AF; Frid A; Wedel H; Ahlén E; Nyström T; Hellman J
    JAMA; 2017 Jan; 317(4):379-387. PubMed ID: 28118454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised controlled trial of additional bolus insulin using an insulin-to-protein ratio compared with insulin-to-carbohdrate ratio alone in people with type 1 diabetes following a carbohydrate-restricted diet.
    Hall RM; Marshall HJ; Parry-Strong A; Corley B; Krebs JD
    J Diabetes Complications; 2024 Jul; 38(7):108778. PubMed ID: 38820834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a New Tool to Assess Bolus Calculation and Carbohydrate Estimation.
    Ehrmann D; Hermanns N; Reimer A; Weißmann J; Haak T; Kulzer B
    Diabetes Technol Ther; 2016 Mar; 18(3):194-9. PubMed ID: 26907638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of carbohydrate counting using bolus calculators on glycemic control in type 1 diabetes patients during continuous subcutaneous insulin infusion.
    Yamada E; Okada S; Nakajima Y; Bastie CC; Tagaya Y; Osaki A; Shimoda Y; Shibusawa R; Saito T; Ozawa A; Yamada M
    J Diabetes Investig; 2017 Jul; 8(4):496-500. PubMed ID: 27896954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial.
    Billings LK; Doshi A; Gouet D; Oviedo A; Rodbard HW; Tentolouris N; Grøn R; Halladin N; Jodar E
    Diabetes Care; 2018 May; 41(5):1009-1016. PubMed ID: 29483185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.